Buscar
Mostrando ítems 1-10 de 84
Pharmacogenomics of vitamin K antagonists
(SOC MEDICA SANTIAGO, 2020)
Clinical applications of pharmacogenomics Farmacogenómica como herramienta fundamental para la medicina personalizada: Aplicaciones en la práctica clínica
(Sociedad Medica de Santiago, 2017)
© 2017, Sociedad Medica de Santiago. All rights reserved. Pharmacogenomics is an emergent field aimed at tailoring pharmacological therapy. Genetic polymorphisms can modify the expression and function of enzymes and proteins ...
Pharmacogenomics in psychiatric practice: Latin America initiatives
(Nova Science, 2017)
Pharmacogenomics has had a good development in most of medical specialties, nevertheless in psychiatry has been particularly successful. Accordingly, it has been extremely useful in psychiatric patients considering how ...
Pharmacogenomics of Hypertension and Preeclampsia: Focus on Gene-Gene Interactions
(Frontiers Media Sa, 2018-02-28)
Hypertension is a leading cause of cardiovascular mortality, but only about half of patients on antihypertensive therapy achieve blood pressure control. Preeclampsia is defined as pregnancy-induced hypertension and ...
Pharmacogenomics of antiretroviral therapy in Latin America
(Nova Science, 2017)
AIDS is caused by infection with human immunodeficiency virus (HIV), which when untreated produces a critical decline in CD4+ T cells, triggering a progressive dysfunction of the immune system and the development of ...
Farmacogenómica como herramienta fundamental para la medicina personalizada: aplicaciones en la práctica clínica
(Sociedad Médica de Santiago, 2017)
Pharmacogenomics is an emergent field aimed at tailoring pharmacological
therapy. Genetic polymorphisms can modify the expression and
function of enzymes and proteins involved in drug metabolism, affecting
absorption, ...
Farmacogenómica como herramienta fundamental para la medicina personalizada: aplicaciones en la práctica clínica
(Sociedad Médica de Santiago, 2017-04)
Pharmacogenomics is an emergent field aimed at tailoring pharmacological therapy. Genetic polymorphisms can modify the expression and function of enzymes and proteins involved in drug metabolism, affecting absorption, ...
Frequencies of variants in genes associated with dyslipidemias identified in Costa Rican genomes
(2023)
Dyslipidemias are risk factors in diseases of significant importance to public health, such as atherosclerosis, a condition that contributes to the development of cardiovascular diseases, respectively. Unhealthy lifestyles, ...
A pharmacogenomic dissection of a Rosuvastatin-induced rhabdomyolysis case evokes the polygenic nature of adverse drug reactions
Rosuvastatin, is a widely-used statin for the treatment of hypercholesterolemia and the prevention of cardiovascular diseases. Although rosuvastatin is well tolerated, about 3/10.000 patients can suffer severe myopathy. ...